Approximately, 78% (mean over 11 samples) of the CML lin(−) cells were positive for CD34 surface marker compared to 34% in normal lin(−) cells (Supplementary Table 1, Supplementary Fig. 1). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.